Gilead Sciences EBITDA 2012-2025 | GILD

Gilead Sciences annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Gilead Sciences EBITDA for the quarter ending September 30, 2025 was $4.013B, a 154.31% increase year-over-year.
Gilead Sciences EBITDA for the twelve months ending September 30, 2025 was $13.256B, a 269.76% increase year-over-year.
Gilead Sciences 2024 annual EBITDA was $4.429B, a 56.99% decline from 2023.
Gilead Sciences 2023 annual EBITDA was $10.298B, a 9.17% increase from 2022.
Gilead Sciences 2022 annual EBITDA was $9.433B, a 21.18% decline from 2021.

Gilead Sciences Annual EBITDA (Millions of US $)
2024	$4,429
2023	$10,298
2022	$9,433
2021	$11,968
2020	$5,551
2019	$5,691
2018	$9,629
2017	$15,410
2016	$18,791
2015	$23,291
2014	$16,315
2013	$4,869
2012	$4,288
2011	$4,092

Gilead Sciences Quarterly EBITDA (Millions of US $)
2025-09-30	$4,013
2025-06-30	$3,165
2025-03-31	$2,933
2024-12-31	$3,145
2024-09-30	$1,578
2024-06-30	$3,338
2024-03-31	$-3,632
2023-12-31	$2,301
2023-09-30	$3,307
2023-06-30	$2,346
2023-03-31	$2,344
2022-12-31	$2,795
2022-09-30	$3,362
2022-06-30	$2,554
2022-03-31	$722
2021-12-31	$1,475
2021-09-30	$4,365
2021-06-30	$2,765
2021-03-31	$3,363
2020-12-31	$3,078
2020-09-30	$2,356
2020-06-30	$-2,634
2020-03-31	$2,751
2019-12-31	$1,443
2019-09-30	$-1,126
2019-06-30	$2,778
2019-03-31	$2,596
2018-12-31	$1,502
2018-09-30	$2,981
2018-06-30	$2,636
2018-03-31	$2,510
2017-12-31	$2,688
2017-09-30	$4,109
2017-06-30	$4,552
2017-03-31	$4,061
2016-12-31	$4,337
2016-09-30	$4,698
2016-06-30	$4,822
2016-03-31	$4,934
2015-12-31	$5,899
2015-09-30	$5,863
2015-06-30	$5,889
2015-03-31	$5,640
2014-12-31	$4,605
2014-09-30	$3,748
2014-06-30	$4,678
2014-03-31	$3,284
2013-12-31	$1,325
2013-09-30	$1,217
2013-06-30	$1,227
2013-03-31	$1,100
2012-12-31	$1,180
2012-09-30	$1,115
2012-06-30	$1,127
2012-03-31	$866
2011-12-31	$941
2011-09-30	$1,077
2011-06-30	$1,092
2011-03-31	$983

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$150.246B	$28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$293.552B	20.71
Amgen (AMGN)	United States	$175.599B	14.91
Vertex Pharmaceuticals (VRTX)	United States	$117.690B	30.30
Bristol Myers Squibb (BMY)	United States	$113.717B	8.52
GSK (GSK)	United Kingdom	$102.715B	11.38
Regeneron Pharmaceuticals (REGN)	United States	$83.717B	21.72
CSL (CSLLY)	Australia	$56.792B	0.00
Alnylam Pharmaceuticals (ALNY)	United States	$52.620B	1731.69
Argenex SE (ARGX)	Netherlands	$48.546B	60.28
Insmed (INSM)	United States	$37.530B	0.00
Biogen (BIIB)	United States	$27.524B	11.21
Royalty Pharma (RPRX)	United States	$23.188B	8.89
Revolution Medicines (RVMD)	United States	$22.935B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$22.643B	0.00
BioNTech SE (BNTX)	Germany	$22.484B	0.00
Genmab (GNMSF)	Denmark	$22.465B	16.48
Genmab (GMAB)	Denmark	$22.008B	16.55
Illumina (ILMN)	United States	$21.556B	32.36
Incyte (INCY)	United States	$20.981B	20.09
Exact Sciences (EXAS)	United States	$19.347B	537.42
Roivant Sciences (ROIV)	United Kingdom	$15.287B	0.00
Guardant Health (GH)	United States	$13.886B	0.00
Moderna (MRNA)	United States	$13.402B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.024B	24.23
Ascendis Pharma (ASND)	Denmark	$12.581B	0.00
Exelixis (EXEL)	United States	$11.808B	18.90
BioMarin Pharmaceutical (BMRN)	United States	$11.325B	20.54
Avidity Biosciences (RNA)	United States	$10.904B	0.00
Bio-Techne Corp (TECH)	United States	$10.237B	38.20
QIAGEN (QGEN)	Netherlands	$10.198B	19.36
Jazz Pharmaceuticals (JAZZ)	Ireland	$9.791B	38.18
Repligen (RGEN)	United States	$9.390B	100.49
Abivax SA (ABVX)	France	$8.915B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$8.772B	0.00
Axsome Therapeutics (AXSM)	United States	$8.539B	0.00
Halozyme Therapeutics (HALO)	United States	$8.522B	13.62
Bio-Rad Laboratories (BIO.B)	United States	$8.381B	30.14
Cytokinetics (CYTK)	United States	$7.643B	0.00
Nuvalent (NUVL)	United States	$7.638B	0.00
Krystal Biotech (KRYS)	United States	$7.580B	39.19
Praxis Precision Medicines (PRAX)	United States	$7.268B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.742B	0.00
PTC Therapeutics (PTCT)	United States	$6.225B	8.45
Vaxcyte (PCVX)	United States	$6.028B	0.00
Belite Bio (BLTE)	United States	$5.941B	0.00
Kymera Therapeutics (KYMR)	United States	$5.380B	0.00
Apogee Therapeutics (APGE)	United States	$5.328B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.131B	0.00
Anbio Biotechnology (NNNN)	Germany	$5.035B	0.00
Cogent Biosciences (COGT)	United States	$5.033B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.015B	129.39
Celcuity (CELC)	United States	$4.975B	0.00
Alkermes (ALKS)	Ireland	$4.897B	14.40
Zealand Pharma (ZLDPF)	Denmark	$4.676B	4.74
Immunovant (IMVT)	United States	$4.562B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.531B	38.26
TG Therapeutics (TGTX)	United States	$4.520B	10.24
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.449B	0.00
Amicus Therapeutics (FOLD)	United States	$4.406B	357.00
CG Oncology (CGON)	United States	$4.372B	0.00
Legend Biotech (LEGN)	United States	$4.359B	0.00
Scholar Rock Holding (SRRK)	United States	$4.303B	0.00
ADMA Biologics Inc (ADMA)	United States	$4.272B	30.42
Structure Therapeutics (GPCR)	United States	$4.163B	0.00
Ligand Pharmaceuticals (LGND)	United States	$4.067B	99.83
GRAIL (GRAL)	United States	$3.902B	0.00
Arcellx (ACLX)	United States	$3.832B	0.00
Viking Therapeutics (VKTX)	United States	$3.616B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.457B	0.00
Apellis Pharmaceuticals (APLS)	United States	$3.454B	88.07
IDEAYA Biosciences (IDYA)	United States	$3.277B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.263B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.257B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.234B	94.82
Terns Pharmaceuticals (TERN)	United States	$3.196B	0.00
Liquidia (LQDA)	United States	$3.120B	0.00
Vera Therapeutics (VERA)	United States	$3.114B	0.00
Travere Therapeutics (TVTX)	United States	$3.094B	0.00
Viridian Therapeutics (VRDN)	United States	$3.030B	0.00
Disc Medicine (IRON)	United States	$2.950B	0.00
Beam Therapeutics (BEAM)	United States	$2.796B	0.00
Nuvation Bio (NUVB)	United States	$2.756B	0.00
Mesoblast (MESO)	Australia	$2.689B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.686B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.641B	0.00
Edgewise Therapeutics (EWTX)	United States	$2.636B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.568B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.561B	0.00
Denali Therapeutics (DNLI)	United States	$2.505B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.497B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.451B	6.65
Recursion Pharmaceuticals (RXRX)	United States	$2.422B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.406B	0.00
Spyre Therapeutics (SYRE)	United States	$2.375B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.314B	0.00
ImmunityBio (IBRX)	United States	$2.295B	0.00
Arcus Biosciences (RCUS)	United States	$2.269B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.220B	12.12
Ultragenyx Pharmaceutical (RARE)	United States	$2.172B	0.00
Twist Bioscience (TWST)	United States	$2.164B	0.00
Zai Lab (ZLAB)	China	$2.077B	0.00
Alumis (ALMS)	United States	$2.042B	0.00
Vericel (VCEL)	United States	$1.950B	160.67
Maze Therapeutics (MAZE)	United States	$1.940B	0.00
Immunome (IMNM)	United States	$1.932B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.928B	0.00
Erasca (ERAS)	United States	$1.918B	0.00
Stoke Therapeutics (STOK)	United States	$1.876B	49.03
Syndax Pharmaceuticals (SNDX)	United States	$1.825B	0.00
Celldex Therapeutics (CLDX)	United States	$1.819B	0.00
Dynavax Technologies (DVAX)	United States	$1.810B	53.14
MannKind (MNKD)	United States	$1.796B	58.50
Sionna Therapeutics (SION)	United States	$1.752B	0.00
Zymeworks (ZYME)	United States	$1.734B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.714B	13.29
NeoGenomics (NEO)	United States	$1.703B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.668B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.657B	0.00
Dianthus Therapeutics (DNTH)	United States	$1.637B	0.00
Precigen (PGEN)	United States	$1.624B	0.00
Upstream Bio (UPB)	United States	$1.608B	0.00
NovoCure (NVCR)	Jersey	$1.607B	0.00
Fortrea Holdings (FTRE)	United States	$1.607B	34.10
Tango Therapeutics (TNGX)	United States	$1.582B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.581B	75.88
UniQure (QURE)	Netherlands	$1.577B	0.00
Tyra Biosciences (TYRA)	United States	$1.564B	0.00
Certara (CERT)	United States	$1.486B	27.44
Nurix Therapeutics (NRIX)	United States	$1.484B	0.00
Kodiak Sciences (KOD)	United States	$1.471B	0.00
Trevi Therapeutics (TRVI)	United States	$1.434B	0.00
MBX Biosciences (MBX)	United States	$1.422B	0.00
Alvotech (ALVO)	Luxembourg	$1.399B	20.17
Rapport Therapeutics (RAPP)	United States	$1.380B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.363B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.362B	0.00
Pharvaris (PHVS)	Netherlands	$1.354B	0.00
EyePoint (EYPT)	United States	$1.344B	0.00
AbCellera Biologics (ABCL)	Canada	$1.308B	0.00
Pharming Group (PHAR)	Netherlands	$1.282B	0.00
AnaptysBio (ANAB)	United States	$1.237B	0.00
Sana Biotechnology (SANA)	United States	$1.215B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.208B	0.00
Intellia Therapeutics (NTLA)	United States	$1.202B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.188B	0.00
Novavax (NVAX)	United States	$1.181B	3.00
Biohaven (BHVN)	United States	$1.176B	0.00
Castle Biosciences (CSTL)	United States	$1.148B	157.36
Septerna (SEPN)	United States	$1.133B	0.00
Immatics (IMTX)	Germany	$1.115B	0.00
Pharming Group (PHGUF)	Netherlands	$1.107B	165.00
Palvella Therapeutics (PVLA)	United States	$1.094B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.072B	0.00
Inhibrx Biosciences (INBX)	United States	$1.060B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.058B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$1.055B	0.00
Pacira BioSciences (PCRX)	United States	$1.012B	11.59
Urogen Pharma (URGN)	United States	$0.995B	0.00
Nanobiotix S.A - (NBTX)	France	$0.994B	0.00
Ventyx Biosciences (VTYX)	United States	$0.985B	0.00
Bicara Therapeutics (BCAX)	United States	$0.983B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.973B	0.00
Compass Therapeutics (CMPX)	United States	$0.952B	0.00
Rapt Therapeutics (RAPT)	United States	$0.932B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$0.918B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
MiMedx (MDXG)	United States	$0.903B	16.05
Oric Pharmaceuticals (ORIC)	United States	$0.891B	0.00
Arbutus Biopharma (ABUS)	United States	$0.889B	0.00
YD Bio (YDES)		$0.870B	0.00
Zenas BioPharma (ZBIO)	United States	$0.863B	0.00
Geron (GERN)	United States	$0.855B	0.00
Janux Therapeutics (JANX)	United States	$0.852B	0.00
ArriVent BioPharma (AVBP)	United States	$0.847B	0.00
Kura Oncology (KURA)	United States	$0.819B	0.00
MapLight Therapeutics (MPLT)	United States	$0.818B	0.00
Vir Biotechnology (VIR)	United States	$0.814B	0.00
GH Research (GHRS)	Ireland	$0.781B	0.00
Arvinas (ARVN)	United States	$0.775B	0.00
REGENXBIO (RGNX)	United States	$0.739B	0.00
CytomX Therapeutics (CTMX)	United States	$0.737B	10.88
Astria Therapeutics (ATXS)	United States	$0.735B	0.00
Gyre Therapeutics (GYRE)	United States	$0.713B	92.50
Prime Medicine (PRME)	United States	$0.711B	0.00
Inventiva S.A (IVA)	France	$0.705B	0.00
Cytek Biosciences (CTKB)	United States	$0.697B	0.00
DBV Technologies S.A (DBVT)	France	$0.683B	0.00
Emergent Biosolutions (EBS)	United States	$0.681B	6.55
Bright Minds Biosciences (DRUG)	United States	$0.675B	0.00
Jade Biosciences (JBIO)	United States	$0.667B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.644B	0.00
Evommune (EVMN)	United States	$0.635B	0.00
Replimune (REPL)	United States	$0.630B	0.00
Annexon (ANNX)	United States	$0.628B	0.00
Myriad Genetics (MYGN)	United States	$0.613B	0.00
CorMedix Inc (CRMD)	United States	$0.601B	5.57
MeiraGTx Holdings (MGTX)	United States	$0.596B	0.00
EnGene Holdings (ENGN)	Canada	$0.590B	0.00
Invivyd (IVVD)	United States	$0.587B	0.00
Keros Therapeutics (KROS)	United States	$0.585B	12.47
Gossamer Bio (GOSS)	United States	$0.579B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.560B	0.00
Design Therapeutics (DSGN)	United States	$0.535B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.533B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.524B	0.00
Niagen Bioscience (NAGE)	United States	$0.520B	40.75
Verastem (VSTM)	United States	$0.520B	0.00
Alto Neuroscience (ANRO)	United States	$0.509B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.507B	0.00
BioAge Labs (BIOA)	United States	$0.503B	0.00
Absci (ABSI)	United States	$0.501B	0.00
Prothena (PRTA)	Ireland	$0.495B	0.00
SELLAS Life Sciences (SLS)	United States	$0.493B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.482B	0.00
Ocugen (OCGN)	United States	$0.468B	0.00
LENZ Therapeutics (LENZ)	United States	$0.465B	0.00
Kamada (KMDA)	Israel	$0.462B	22.33
Bicycle Therapeutics (BCYC)	United Kingdom	$0.461B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.453B	0.00
PepGen (PEPG)	United States	$0.445B	0.00
Prima BioMed (IMMP)	Australia	$0.435B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.433B	0.00
NovaBridge Biosciences (NBP)	United States	$0.427B	0.00
PureTech Health (PRTC)	United States	$0.425B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.425B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.425B	0.00
Monopar Therapeutics (MNPR)	United States	$0.421B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.415B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.413B	0.00
Solid Biosciences (SLDB)	United States	$0.412B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.404B	0.00
Benitec Biopharma (BNTC)	United States	$0.401B	0.00
BGM Group (BGM)	China	$0.387B	0.00
Tectonic Therapeutic (TECX)	United States	$0.385B	0.00
Allogene Therapeutics (ALLO)	United States	$0.384B	0.00
Entrada Therapeutics (TRDA)	United States	$0.383B	0.00
Anavex Life Sciences (AVXL)	United States	$0.382B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.378B	0.00
Neumora Therapeutics (NMRA)	United States	$0.371B	0.00
XOMA Royalty (XOMA)	United States	$0.370B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.364B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.350B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.350B	0.00
Climb Bio (CLYM)	United States	$0.343B	0.00
AC Immune (ACIU)	Switzerland	$0.342B	0.00
Zura Bio (ZURA)	United States	$0.333B	0.00
Amarin (AMRN)	Ireland	$0.329B	0.00
Aura Biosciences (AURA)	United States	$0.323B	0.00
Candel Therapeutics (CADL)	United States	$0.313B	0.00
Aardvark Therapeutics (AARD)	United States	$0.311B	0.00
Puma Biotechnology (PBYI)	United States	$0.308B	8.26
GENFIT S.A (GNFTY)	France	$0.303B	0.00
Shattuck Labs (STTK)	United States	$0.301B	0.00
Immuneering (IMRX)	United States	$0.301B	0.00
Forte Biosciences (FBRX)	United States	$0.299B	0.00
Palisade Bio (PALI)	United States	$0.297B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.292B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.292B	0.00
Jyong Biotech (MENS)	Taiwan	$0.290B	0.00
Lifecore Biomedical (LFCR)	United States	$0.283B	0.00
Abeona Therapeutics (ABEO)	United States	$0.281B	4.59
CAMP4 Therapeutics (CAMP)	United States	$0.278B	0.00
Neurogene (NGNE)	United States	$0.278B	0.00
Contineum Therapeutics (CTNM)	United States	$0.272B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.271B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.270B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.270B	0.00
Adherex Technologies (FENC)	United States	$0.265B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.261B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.260B	0.00
Rezolute (RZLT)	United States	$0.244B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Alpha Teknova (TKNO)	United States	$0.224B	0.00
Voyager Therapeutics (VYGR)	United States	$0.224B	0.00
Humacyte (HUMA)	United States	$0.219B	0.00
Nuvectis Pharma (NVCT)	United States	$0.217B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.213B	0.00
Cardiff Oncology (CRDF)	United States	$0.207B	0.00
C4 Therapeutics (CCCC)	United States	$0.207B	0.00
Coherus Oncology (CHRS)	United States	$0.204B	0.00
Alector (ALEC)	United States	$0.203B	0.00
Cabaletta Bio (CABA)	United States	$0.202B	0.00
Editas Medicine (EDIT)	United States	$0.202B	0.00
Sagimet Biosciences (SGMT)	United States	$0.202B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.193B	0.00
Cybin (HELP)	Canada	$0.190B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.186B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.183B	0.00
SAB Biotherapeutics (SABS)	United States	$0.175B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.174B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.170B	0.00
Compugen (CGEN)	Israel	$0.168B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.167B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.166B	0.00
Innate Pharma S.A (IPHA)	France	$0.165B	0.00
Immix Biopharma (IMMX)	United States	$0.164B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.160B	7.81
Caribou Biosciences (CRBU)	United States	$0.155B	0.00
MaxCyte (MXCT)	United States	$0.153B	0.00
Crescent Biopharma (CBIO)	United States	$0.150B	0.00
Quince Therapeutics (QNCX)	United States	$0.150B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.149B	0.00
Nkarta (NKTX)	United States	$0.148B	0.00
Codexis (CDXS)	United States	$0.148B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Spero Therapeutics (SPRO)	United States	$0.144B	0.00
Actuate Therapeutics (ACTU)	United States	$0.143B	0.00
Alpha Cognition (ACOG)	Canada	$0.142B	0.00
Seres Therapeutics (MCRB)	United States	$0.142B	0.00
Elicio Therapeutics (ELTX)	United States	$0.141B	0.00
Vor Biopharma (VOR)		$0.141B	0.00
VTv Therapeutics (VTVT)	United States	$0.140B	0.00
Anika Therapeutics (ANIK)	United States	$0.137B	0.00
Turn Therapeutics (TTRX)	United States	$0.136B	0.00
Fortress Biotech (FBIO)	United States	$0.133B	0.00
Opus Genetics (IRD)	United States	$0.133B	0.00
Agenus (AGEN)	United States	$0.133B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.127B	0.00
Cognition Therapeutics (CGTX)	United States	$0.124B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.124B	0.00
Fate Therapeutics (FATE)	United States	$0.121B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.120B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.119B	0.00
Ovid Therapeutics (OVID)	United States	$0.119B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.111B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.110B	0.00
Repare Therapeutics (RPTX)	Canada	$0.110B	0.00
Seer (SEER)	United States	$0.109B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.109B	0.00
Scilex Holding (SCLX)	United States	$0.109B	0.00
Genelux (GNLX)	United States	$0.107B	0.00
Sutro Biopharma (STRO)	United States	$0.104B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.104B	0.00
OKYO Pharma (OKYO)		$0.104B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.104B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.103B	0.00
Tharimmune (THAR)	United States	$0.102B	0.00
Coya Therapeutics (COYA)	United States	$0.101B	0.00
Biomea Fusion (BMEA)	United States	$0.100B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.099B	6.27
Annovis Bio (ANVS)	United States	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Citius Oncology (CTOR)	United States	$0.092B	0.00
Spruce Biosciences (SPRB)	United States	$0.086B	0.00
CalciMedica (CALC)	United States	$0.084B	0.00
BioStem Technologies (BSEM)		$0.084B	5.88
Tenax Therapeutics (TENX)	United States	$0.083B	0.00
BioHarvest Sciences (BHST)	Canada	$0.082B	0.00
Pliant Therapeutics (PLRX)	United States	$0.081B	0.00
EXoZymes (EXOZ)	United States	$0.081B	0.00
Immunic (IMUX)	United States	$0.080B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.079B	0.00
XBiotech (XBIT)	United States	$0.078B	0.00
ImageneBio (IMA)	United States	$0.078B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.077B	0.00
Adicet Bio (ACET)	United States	$0.077B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.076B	0.00
MediciNova (MNOV)	United States	$0.075B	0.00
Entera Bio (ENTX)	Israel	$0.073B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.073B	0.00
Adagene (ADAG)	China	$0.072B	0.00
CervoMed (CRVO)	United States	$0.072B	0.00
ATyr Pharma (ATYR)	United States	$0.070B	0.00
InflaRx (IFRX)	Germany	$0.070B	0.00
Equillium (EQ)	United States	$0.069B	0.00
TScan Therapeutics (TCRX)	United States	$0.069B	0.00
Clene (CLNN)	United States	$0.066B	0.00
BeyondSpring (BYSI)	United States	$0.064B	0.00
Passage Bio (PASG)	United States	$0.063B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.062B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.061B	0.00
IBio (IBIO)	United States	$0.061B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.059B	0.00
MiNK Therapeutics (INKT)	United States	$0.058B	0.00
Grace Therapeutics (GRCE)	United States	$0.057B	0.00
Aligos Therapeutics (ALGS)	United States	$0.055B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.054B	0.00
ABVC BioPharma (ABVC)	United States	$0.053B	0.00
PDS Biotechnology (PDSB)	United States	$0.052B	0.00
Precision BioSciences (DTIL)	United States	$0.052B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
NextCure (NXTC)	United States	$0.047B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.047B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
Estrella Immunopharma (ESLA)	United States	$0.045B	0.00
Q32 Bio (QTTB)	United States	$0.044B	0.00
TELA Bio (TELA)	United States	$0.044B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.044B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.043B	0.00
OnKure Therapeutics (OKUR)	United States	$0.043B	0.00
Jasper Therapeutics (JSPR)	United States	$0.042B	0.00
RenovoRx (RNXT)	United States	$0.041B	0.00
IO Biotech (IOBT)	Denmark	$0.040B	0.00
INmune Bio (INMB)	United States	$0.040B	0.00
Lantern Pharma (LTRN)	United States	$0.039B	0.00
Medicus Pharma (MDCX)	United States	$0.039B	0.00
TuHURA Biosciences (HURA)	United States	$0.039B	0.00
Oncobiologics (OTLK)	United States	$0.038B	0.00
Exicure (XCUR)	United States	$0.037B	0.00
Celularity (CELU)	United States	$0.037B	0.00
Generation Bio (GBIO)	United States	$0.037B	0.00
Xilio Therapeutics (XLO)	United States	$0.036B	0.00
AN2 Therapeutics (ANTX)	United States	$0.036B	0.00
Femasys (FEMY)	United States	$0.035B	0.00
Dyadic (DYAI)	United States	$0.034B	0.00
Galecto (GLTO)	Denmark	$0.033B	0.00
Skye Bioscience (SKYE)	United States	$0.031B	0.00
Cingulate (CING)	United States	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.031B	0.00
Elutia (ELUT)	United States	$0.031B	0.00
Rein Therapeutics (RNTX)	United States	$0.031B	0.00
Pluri (PLUR)	Israel	$0.030B	0.00
Rallybio (RLYB)	United States	$0.030B	0.00
Boundless Bio (BOLD)	United States	$0.029B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.029B	0.00
Senti Biosciences (SNTI)	United States	$0.029B	0.00
Cue Biopharma (CUE)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.027B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.027B	0.00
Hyperion DeFi (HYPD)	United States	$0.027B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Quantum Biopharma (QNTM)	Canada	$0.026B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.026B	0.00
Intensity Therapeutics (INTS)	United States	$0.025B	0.00
Apollomics (APLM)	United States	$0.024B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.023B	0.00
FibroBiologics (FBLG)	United States	$0.022B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.022B	0.00
BioAtla (BCAB)	United States	$0.021B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.019B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.018B	0.00
MetaVia (MTVA)	United States	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Lisata Therapeutics (LSTA)	United States	$0.017B	0.00
Hoth Therapeutics (HOTH)	United States	$0.017B	0.00
Bionano Genomics (BNGO)	United States	$0.016B	0.00
Cocrystal Pharma (COCP)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Black Titan (BTTC)	United States	$0.015B	0.00
BioCardia (BCDA)	United States	$0.015B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.015B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
Synlogic (SYBX)	United States	$0.013B	0.00
Polyrizon (PLRZ)	Israel	$0.013B	0.00
Longeveron (LGVN)	United States	$0.013B	0.00
Edesa Biotech (EDSA)	Canada	$0.013B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Novogen (KZIA)	Australia	$0.011B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.011B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.011B	0.00
Abpro Holdings (ABP)	United States	$0.011B	0.00
Curis (CRIS)	United States	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Biorestorative Therapies (BRTX)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.010B	0.00
NewcelX (NCEL)	Switzerland	$0.010B	0.00
IN8bio (INAB)	United States	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
Purple Biotech (PPBT)	Israel	$0.009B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
Moleculin Biotech (MBRX)	United States	$0.008B	0.00
Gelteq (GELS)	Australia	$0.008B	0.00
Advanced Biomed (ADVB)	United States	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.007B	0.00
Beyond Air (XAIR)	United States	$0.007B	0.00
IMMURON (IMRN)	Australia	$0.007B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.007B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
Aprea Therapeutics (APRE)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Sunshine Biopharma (SBFM)	United States	$0.007B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.006B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
Revelation Biosciences (REVB)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
GeoVax Labs (GOVX)	United States	$0.005B	0.00
Arcadia Biosciences (RKDA)	United States	$0.004B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.004B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
Ensysce Biosciences (ENSC)	United States	$0.004B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
Alps Group (ALPS)	United States	$0.003B	2.98
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.002B	0.00
Psyence Biomedical (PBM)	Canada	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00